(Q83164419)
Statements
In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab (English)
Dagmar E Ettlinger
Markus Mitterhauser
Wolfgang Wadsak
Eva Ostermann
Johann Schueller
Martin Czejka